A 13-year study at Thomas Jefferson University found that adolescent boys and men who receive the HPV vaccine have a significantly lower risk of developing head and neck cancer. HPV, a common sexually transmitted infection, is linked to up to 70% of head and neck cancers in men. The study reviewed health records from approximately 1.5 million vaccinated men and found a 54% reduced cancer risk in this population. The HPV vaccine was first approved in 2006 to reduce the risk of cervical cancer and precancerous conditions in adolescent girls. These findings highlight the importance of HPV vaccination for both genders to prevent various cancers. Tanenbaum, M 2024, 'HPV vaccine reduces risk of head and neck cancers in men, study shows', Philly Voice, www.phillyvoice.com/hpv-vaccine-men-cancer-head-neck-risk-women-cervical-cancer/?eType=EmailBlastContent&eId=0076a59b-b736-4e26-9ce7-035f3fa5fdab, Accessed 12 July 2024.
TOP